PubMed COVID-19 Clinical Care

CONCLUSION: Symptoms of Long COVID in children are common and impact their quality of life. The importance of further unraveling the pathophysiology of acute and long-term symptoms following SARS-CoV-2 infection in children is vital as well as

Aim: Preexisting anti-polyethylene glycol (PEG) antibodies (APAs) may affect the efficacy and safety of PEGylated compounds. Omontys^(®) and Krystexxa^(®) withdrawal and SARS-CoV-2 RNA vaccine anaphylaxis have all been linked to APAs. This project

No abstract

CONCLUSIONS.: COVID-19 had an emotional impact on people with mental health problems; in turn, CMHC services were affected by the type of care (face-to-face or virtual), resources, frequency, time and quality of care, finding limitations and benefits

COVID-19 vaccine hesitancy and suboptimal vaccine uptake rates are pressing public health challenges. Vaccine hesitancy has been observed for different vaccines. For COVID-19 vaccines, multiple factors influence vaccine uptake in the U.S. including

In diesem Beitrag wird aufgezeigt, dass das Gesundheitspersonal während der COVID-19-Pandemie nicht nur physisch, sondern auch psychisch stark belastet war. Unterschiedliche Risikofaktoren wie ein junges Alter, das weibliche Geschlecht, ein niedriger

Studies suggest perinatal infection with SARS-CoV-2 can induce adverse birth outcomes, but studies published to date have substantial limitations. We therefore conducted an observational study of 211 births occurring between January 2020-September

COVID-19 is a global, highly contagious, predominantly respiratory viral illness caused by coronavirus 2 (SARS-CoV2). Although COVID-19 is mainly a respiratory disease, it can affect other organ systems causing a lot of extrapulmonary manifestations

The continuing emergence of SARS-CoV-2 variants highlights the need to update COVID-19 vaccine compositions. However, immune imprinting induced by vaccination based on the ancestral (hereafter referred to as WT) strain would compromise the antibody

The global emergence of SARS-CoV-2 variants has led to increasing breakthrough infections in vaccinated populations, calling for an urgent need to develop more effective and broad-spectrum vaccines to combat COVID-19. Here we report the preclinical